October 3, 2019, Vancouver, BC – On behalf of LifeSciences BC, Wendy Hurlburt, President and CEO, is pleased to announce the appointment of new members to the LifeSciences BC Board of Directors.
At the recent Board of Directors meeting, Scott Phillips was elected new Chair, Board of Directors with Nancy Harrison moving to Past Chair. Ali Ardakani will remain Vice Chair with Ian Heine, staying on as Treasurer for an extended one-year term.
We sincerely want to thank departing board members; Robin Ciceri, Rich Osborn and Doug Janzen, all of whom made a significant contribution to the organization and its overall management in the last several years. “I can’t be more pleased with the caliber and professional excellence we can draw on from members serving our Board of Directors. LifeSciences BC has always had the most esteemed individuals to call upon to steer our organization and sector forward; it is clear, that we will continue to do so.” Wendy Hurlburt, President and CEO, LifeSciences BC.
To see the full list of LifeSciences BC’s Board of Directors please click here.
For more information contact:
Senior Manager, Communications and External Affairs
Office: 604-669-9909 Ext 6
About LifeSciences BC
LifeSciences BC is a not-for-profit, non-government, industry association that supports and represents the life sciences community of British Columbia through leadership, facilitation of investment and partnering, advocacy, and promotion of our world-class science and industry.
Life sciences sectors, from biopharmaceuticals and medical technology, to digital health and medical devices, are integrated into our organization and all that we do, ensuring that no life sciences sector is working in isolation — and that all sectors come together in a comprehensive, complementary and coordinated fashion.
Throughout the year, LifeSciences BC undertakes numerous programs and projects in support of these sectors. These include public policy initiatives, facilitating trade missions between global industry and our local organizations, raising the profile of our industry internationally and thus facilitating investment and global partnering opportunities, and helping nurture economic development in British Columbia through the life sciences industry.